Amprenavir (Agenerase): News
- Agenerase (Amprenavir) Oral Solution and 50-mg Capsules to Be Discontinued in the U.S. (October 2007)
To read PDF, click here.
From GlaxoSmithKline
- FDA Bits: 3TC, Amprenavir and Nandrolone (September 2002)
Once-a-day dosing for 3TC (Epivir) approved; new interaction warnings for amprenavir (Agenerase); nandrolone decanoate returns to the U.S. market.
In HIV Treatment ALERTS!, from The Center for AIDS
- FDA Approves New Dosing for Amprenavir and Ritonavir Combination (March 8, 2002)
In AIDS Treatment News, from AIDS Treatment News
- New Dosing Regimen for Agenerase and Norvir (February 13, 2002)
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project
- Amprenavir Oral Solution Warning (March 2001)
In What's New, from Project Inform
- What's New in Treatment Information? Amprenavir Oral Solution Warning (June 2000)
In What's New, from Project Inform
- New Safety Warning for Liquid Amprenavir (May 5, 2000)
In STEP Ezine, from Seattle Treatment Education Project
- Amprenavir (Agenerase®) Oral Solution: Warning for Some Patients (May 5, 2000)
In AIDS Treatment News, from AIDS Treatment News
- Treatment Briefs: Agenerase Oral Solution Warning (Spring 2000)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Dose Adjustments When Using Amprenavir (September 1999)
In Project Inform Perspective, from Project Inform
- Fifth Protease Inhibitor Approved (June 1999)
In Body Positive, from Body Positive
- Amprenavir Approved: New (Possible) 2nd Generation PI Hits the Market (Summer 1999)
In STEP Perspective, from Seattle Treatment Education Project
- Amprenavir, New Protease Inhibitor, Approved (May 7, 1999)
From AIDS Treatment News
- FDA Approves an AIDS Drug From Vertex (April 19, 1999)
Approval of Agenerase, the fifth drug targeting HIV's protease enzyme.
From U.S. Centers for Disease Control and Prevention
- FDA Approves Amprenavir for HIV Infection (April 16, 1999)
From U.S. Food and Drug Administration
|
Advertisement
|
Email
Glossary
